Trial Profile
Oral alendronate for osteoporosis treatment in non-walking children with cerebral palsy
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 02 Aug 2022
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 02 Jul 2012 New trial record